Open access
Oct 2026
ADHERE-DM: Assessing Bupropion for self-care adherence and glycaemic control in multimorbid type 2 diabetes mellitus with mild depression: A cross-over randomised controlled trial
Type 2 diabetes mellitus (T2DM) and depression needs to be treated as an interconnected condition. Considering T2DM-related concerns amongst antidepressants, bupropion has a favourable metabolic profile including weight control, apart from a lower risk of sexual dysfunction. We studied the role of bupropion in pati...
M. A. Shamim, Ravindra Shukla, M. Swami et al.
· The Indian journal of medica... · 0 citations